I ntegrins are a family of heterodimeric type I transmembrane receptors that are sentinel sensors of the extracellular environment through their mediation of cell adhesive events involved in homeostasis, immunity, tissue repair and neoplasia 1 . Integrin ectodomains are composed of an α and β subunit stably joined at the α -and β -head domain, each connected to a flexible leg, which continues to a single transmembrane helix followed by a short cytoplasmic domain ( Supplementary Fig. 1a ). Integrins utilize the flexibility of their ectodomains to bidirectionally transduce conformational signals to and from the cell interior 2 . In current models of integrin function, regulation of ligand affinity and signaling is thought to be mediated by a series of coupled motions of the ligand-binding headpiece with leg domains, changing the overall shape from a bent to an extended conformation: the so called 'switchblade' model ( Supplementary Fig. 1b) 3 . Despite extensive studies, the mechanistic structural details of integrin extension remain elusive. The opposing model proposes that integrins can regulate ligand affinity and transduce signaling entirely in a bent conformation ( Supplementary Fig. 1c ) 4 . Furthermore, it is not known how integrins probe the extracellular milieu to find target-binding motifs in extracellular matrix proteins, cytokines and growth factors, a function not elucidated by either model.
Three main conformational states are currently proposed: bent integrins with a closed headpiece and extended integrins with either a closed or open headpiece ( Supplementary Fig. 1 ). Crystal structures of integrin ectodomains reveal exclusively bent conformations (Supplementary Table 1 ). Negative-stain electron microscopy (ns-EM) images of numerous integrin heterodimers exhibit all three conformational states, with ligand occupancy favoring the extended-open conformation ( Supplementary Table 1 ). These studies mainly support the prevailing hypothesis that the high-affinity state has an extended-open conformation 5 .
For the α vβ 8 integrin, only the extended-closed form has been observed by ns-EM, either alone or in association with ligand 6, 7 .
Those findings are inconsistent with both the bent and the switchblade models and suggest that the α vβ 8 integrin functions entirely in the extended-closed form ( Supplementary Fig. 1d ). The relative conformational homogeneity of α vβ 8 makes it an ideal target for structural studies of an integrin in the extended conformation.
Here we present single-particle electron cryomicroscopy (cryo-EM) structures of the α vβ 8 integrin in complex with two immunoglobulin antigen-binding fragments (Fab) to reveal an integrin in a range of extended conformations with unprecedented clarity. We achieve an overall resolution of 6.4 Å, with a resolution of 4.8 Å in the headpiece. The motion between the headpiece and the leg suggests a mechanism by which integrin headpieces survey extracellular surfaces for ligands. Our structures predict the interactions between α v thigh and calf-1 domains in this extended conformation, which is confirmed with rationally designed α vβ 3 mutants.
Results
Cryo-EM structures of the αvβ8 integrin. Integrins in an extended conformation have not been crystallized. Current single-particle EM structures do not have sufficient detail to provide insights into integrin extension or surveillance mechanisms (Supplementary Table 1 ). Even with the recent advances in single particle cryo-EM 8 , determining high-resolution integrin structures remains challenging. The main technical barriers are the low mass density, asymmetry and extreme conformational flexibility, all of which conspire to hinder accurate image alignment and conformational classification 9 . To mitigate these challenges, we use two different monoclonal Fabs (8B8 and 68) directed at the headpiece of the α vβ 8 integrin to increase the molecular mass and facilitate more accurate image alignment 10 . Neither Fab alters α vβ 8 function, with 8B8 directed at the α v head and 68 at the β 8 β I-domain 6 . With this combination of Fabs, we determined the structure of the α vβ 8-8B8-68 complex, in which the integrin is in the extended-closed conformation, to
Integrins are conformationally flexible cell surface receptors that survey the extracellular environment for their cognate ligands. Interactions with ligands are thought to be linked to global structural rearrangements involving transitions between bent, extended-closed and extended-open forms. Thus far, structural details are lacking for integrins in the extended conformations due to extensive flexibility between the headpiece and legs in this conformation. Here we present single-particle electron cryomicroscopy structures of human α vβ 8 integrin in the extended-closed conformation, which has been considered to be a low-affinity intermediate. Our structures show the headpiece rotating about a flexible α v knee, suggesting a ligand surveillance mechanism for integrins in their extended-closed form. Our model predicts that the extended conformation is mainly stabilized by an interface formed between flexible loops in the upper and lower domains of the α v leg. Confirming these findings with the α vβ 3 integrin suggests that our model of stabilizing the extended-closed conformation is generalizable to other integrins.
an overall resolution of 6.4 Å ( Fig. 1a , Table 1 and Supplementary  Fig. 2 ). An atomic model of the α vβ 8 integrin in the extended conformation was obtained by fitting homology models of individual domains (based on available crystal structures of integrin α vβ 3) into the cryo-EM density map. Subsequently, the model was iteratively rebuilt and refined into the density using Phenix 11 and Rosetta 12 ( Fig. 1b ). At this resolution, the boundaries for all the individual domains in the α v leg and β 8 headpiece are clearly defined, with well-resolved secondary structural features including all α -helices and many β -sheets ( Fig. 1a,b ).
The inherent conformational flexibilities of integrin leg domains relative to the headpiece and the flexibility of the Fab constant relative to the variable domains (which together account for ~42% of the total mass of the complex) compromise the accuracy of image alignment and limit the overall resolution. By masking out the leg and the constant domains of the Fabs, we improve the resolution of the headpiece to 4.8 Å ( Fig. 1c , Table 1 and Supplementary  Fig. 2c ,f). At this improved resolution, densities of some bulky side chains and glycans of all predicted N-linked glycosylation sites in the headpiece are clearly resolved, serving as excellent landmarks for model building and validation ( Fig. 1d ,e and Supplementary Table 2 ).
Head domain motions: the sunflower model. When image alignment is focused on the headpiece, the leg densities become very weak, indicating the relative flexibility between the head and legs. 3D classification reveals six conformational snapshots, each at subnanometer resolution, with improved leg density ( Supplementary  Fig. 3 ). To approximate the motion of a membrane-anchored integrin, we aligned the α v lower legs of each subclass with each other, revealing different angular positions of the α vβ 8 headpiece as it tilts relative to the leg domains ( Fig. 2a-c ). Individual subclasses reveal complex twisting and angular motions of the headpiece that are associated with varying degrees of contact between the β 8 upper and lower legs with the α v leg. The range of motion of the headpiece is approximately 30° as estimated from the differences between subclasses (i) and (v) ( Fig. 2a-c) .
The intrinsic motion of the headpiece of an integrin joined to flexible legs anchored on the plasma membrane would facilitate surveillance of the extracellular space for ligand detection. The overall effect is that the α vβ 8 head samples an elliptical conic space similar to a sunflower's as the sunflower moves during the day (Supplementary Video 1). Our data provide structural insight into how a single integrin samples a large space, and this motion is presumably beneficial for ligand detection.
Loss of β8 leg contacts with the αv leg favors full receptor extension. The changes in β 8 leg density in the six subclasses suggest a role for the β 8 leg in the sunflower motion. In subclass (i), the β 8 leg density is apparent as a continuous density between the β 8 upper leg that contacts the α v thigh domain and then continues along the α v lower leg (Fig. 2b) . The α vβ 8 headpiece movement through subclasses (ii)-(vi) involves loosening of the contacts that the β 8 upper leg makes with the α v thigh and α v calf-1 domains in subclass (i) ( Fig. 2a-c) . Likewise, the β 8 lower leg density is strongest in subclass (i) and is weaker in subclasses (ii)-(vi), suggesting that the β 8 leg loses contact with the α v leg as α vβ 8 maximally extends ( Supplementary Fig. 4 ).
The resolution of the density map does not permit modeling of the individual domains of the β 8 leg. However, the density map of subclass (i) allows placement of the β 8 PSI-EGF1 domain, which forms the lower portion of the upper β -subunit leg in the integrin headpiece and ectodomain crystal structures, in contact with the C-terminal α v thigh domain ( Fig. 2d ). Contact of the PSI-EGF1 domain with the α v subunit is not observed in subclasses (iii)-(vi) ( Fig. 2e ). Overall, these data suggest that domain contacts between the α v and β 8 legs are not required to maintain the extended conformation.
Following this result, we further hypothesize that in all α v integrins the α v leg alone is sufficient to maintain an extended conformation. To test the role of β -leg in integrin extension, we generate a mutant α vβ 3 integrin ectodomain truncated at the β 3 EGF2 domain ( Fig. 3 ). If the β 3 lower leg is required for extension, the truncation mutant would be predicted to destabilize extension and favor bending. However, ns-EM demonstrates that the lower-leg β 3 deletion mutant has a slight decrease in bent forms compared with the wildtype α vβ 3 integrin ectodomain, suggesting that the β -lower leg does not directly contribute to extension of the α v leg ( Fig. 3a-f ).
The αv hinge. Comparison of the overall and subclassified cryo-EM density maps confirms that the entire lower α v leg is more or less a rigid body, with the main point of motion occurring between the lower α v thigh domain of the upper α v leg and the calf-1 domain of the α v lower leg ( Fig. 2a-c ). In our model the α v thigh domain interfaces extensively with the α v calf-1 domain through interactions between a loop in the α v thigh domain and three loops in the calf-1 domain (Fig. 4a ). These loops are not in contact in the crystal structure of α vβ 3 in the bent conformation 13 . Also, a loop between the C-terminal thigh and N-terminal calf-1 domain designated as the knee region in α vβ 3 crystal structures does not participate in the α v thigh-calf-1 interface in the extended conformation ( Fig. 2d,e ). These two observations suggest a rearrangement of domains from bent to extended conformations so that new interactions are formed to stabilize the extended conformation. Sequence alignment of the PS2 subfamily of integrin α -subunits shows that these predicted interacting loops are highly conserved (Fig. 4b ). To validate our prediction and to generalize our model to other α v integrins, we introduced two cysteine residues (S546C and N685C) into two opposing loops of the α v integrin subunit, one in the thigh loop and the other in loop 2 of the calf-1 domain (Figs. 3g and 4a); this henceforth is referred to as the α vc-c mutant. When paired with either the β 8 or β 3 subunits, it forms two different functional integrin heterodimers. If our model of the extended α v leg is correct, a disulfide bond will form between these two cysteine residues and lock the α v leg into an extended conformation. Consequently, when expressed on the cell surface, α vc-c would be predicted to enhance the function of integrin α vβ 3 by relieving steric hindrance, but not the function of α vβ 8, which is already extended.
Ns-EM of the mutant α vc-cβ 3 ectodomain revealed only extended but no bent integrins ( Fig. 3g -i). In comparison, ns-EM of the wild-type α vβ 3 integrin ectodomain showed all forms ( Fig. 3a-c) . To confirm our findings in vivo, we expressed the full-length mutant and wild-type human α vβ 3 integrins on the cell surface of Chinese hamster ovary (CHO) cells. These cells were sorted to have uniform and equal expression of the mutant and wild-type α v, in addition to β 3 subunits ( Fig. 5a ). The α vc-cβ 3 integrin had increased basal exposure of ligand-induced-binding-site (LIBS) epitopes consistent with a constitutively extended conformation ( Fig. 5a ). Furthermore, the α vc-cβ 3 integrin displayed increased ability to mediate cell adhesion to its ligand, vitronectin, than the wild-type α vβ 3, in both basal and activating cation conditions ( Fig. 5b ). As expected, the α vc-cβ 8 mutant and wild-type human α vβ 8 integrins expressed on CHO cells bound equally to its ligand, latent TGF-β ( Fig. 5c ), and showed no preferential binding under the activating cation conditions, consistent with previous studies 6 . The increased ability of the α vc-cβ 3 integrin to mediate cell adhesion is not due to increased binding affinity, since the mutant and wild-type integrin ectodomains bind equally to their ligands in both basal and activating cation conditions ( Supplementary Fig. 5a ).
Discussion
The integrin α vβ 8 is functionally specialized to bind latent forms of the multifunctional cytokines TGF-β 1 and TGF-β 3 (L-TGF-β ) 14, 15 . The majority of L-TGF-β is not freely diffusible but covalently attached to extracellular matrix or to the cell surface via L-TGF-β binding proteins (for example, LTBP-1) or cell-surface scaffolding proteins (for example, GARP) 16, 17 . Binding of α vβ 8 to cell-or matrix-expressed L-TGF-β results in the release of active TGF-β , a process essential for the homeostatic and pathologic functions of TGF-β in vivo 18 . The α vβ 8 integrin may have evolved, among the five integrins that share the α v subunit, to bias its conformational range toward the extended-closed form to increase the chance of encountering L-TGF-β expressed on an opposing cell or matrix.
Despite pairing with the same α v subunit, α vβ 3 can bend while α vβ 8 does not, indicating that the β -subunit influences integrin conformational dynamics. Our cryo-EM data suggest that contacts between the α v and β 8 lower legs are critical in the tilting of the headpiece during the sunflower motion and that separation of the α v and β 8 lower legs favors further extension. As such, the tilting of the α vβ 8 headpiece may represent an analog of the bent form of α vβ 3, the differences in the magnitude of bending driven by differences within the β 8 lower leg. Experimental mutagenesis or naturally occurring disease-causing mutations in the β 3 lower leg cause constitutive activation and exposure of LIBS epitopes, indicating that such mutations cause extension of the α iibβ 3 integrin 19, 20 . These β 3 mutations often occur in conserved cysteines, which form disulfide loops and are critical determinates of the EGF domain structure of the β 3 lower leg 20 . The β 8 lower leg lacks two of these conserved disulfide pairs in the EGF3 and β -tail domains ( Supplementary  Fig. 5c ). One possibility is that the β 8 lower leg has lost its ability to stabilize the bent conformation, which raises the hypothesis that other integrin β -subunit lower legs stabilize the bent conformation. An alternate hypothesis has been proposed that the β -lower leg contributes to extension via a disulfide loop of EGF2 at the junction between the upper and lower legs of integrin β -subunits, which acts as an entropic spring shifting the conformational equilibrium toward extension 21 . To test these hypotheses, we remove the lower leg of the β 3 subunit containing the entropic spring and found that the conformational ensemble of the α vβ 3 truncation mutant was somewhat biased toward the extended-open conformation. This result favors the hypothesis that the β lower leg stabilizes the bent conformation. Our model of the extended α v leg predicts that two loops between the α v thigh and α v calf-1 domain contribute to stabilizing the extended conformation. We validated this model and suggest that the extended conformation for a α -integrin subunit is stable without contribution from the β lower leg. Furthermore, our data suggest that the β -leg does not cause the extended conformation. On the basis of our data, we hypothesize that the transition from the bent to extended closed conformation requires disrupting or weakening α -β lower leg interactions, which releases the integrin to the extended conformation. Sequence comparison suggests that this model of integrin extension could apply at the very least to the closely related integrin α -subunits α iib, α 5 and α 8, which are strikingly homologous in the interacting loops of the α -thigh and α -calf-1 domains.
α vβ 8 assumes only the extended-closed conformation, yet efficiently binds to and activates L-TGF-β , indicating that the extended-closed conformation of α vβ 8 is functional. Here we generalize this finding to the α vβ 3 integrin by providing evidence that the extended-closed form of α vβ 3 is also functional. This conclusion is based on the fact that when expressed on the cell surface the α vc-cβ 3 mutant exhibits higher basal adhesion than wild-type α vβ 3, while the soluble α vc-cβ 3 and wild-type α vβ 3 ectodomains exhibit identical basal ligand binding. If the regulation of ligand affinity of the membrane-bound and ectodomain-only forms of α vβ 3 is similar, our results suggest that the constitutively extended α vc-cβ 3 is mainly in an extended-closed, low-affinity state and that the functional advantage gained by extension during expression on the cell surface is accessibility to ligand, not increased affinity. These findings raise the possibility that the extended-closed conformation of other integrins is biologically important. In summary, cryo-EM is an advantageous method for determining multiple snapshots at subnanometer resolution of integrins across their dynamic conformational range. Characterizing the motion of α vβ 8 has provided insights into the integrin extension mechanism and has provided a model for ligand surveillance, which we found to also be applicable to α vβ 3. These data suggest that this mechanism for stabilizing integrin extension could be generalizable to other integrins.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0093-x. 
Cell lines and reagents. The antibodies 8B8, 68, AP3, AP5, LIBS1 and LIBS6 have been previously described 6, 22, 23 Protein expression and purification. Wild-type and mutant recombinant human integrin α vβ 8 and α vβ 3 truncated at the junction of the ectodomains and transmembrane domains in pcDNA1neo 25 were expressed using stably expressing CHOLec 3.2.8.1 cells grown in bioreactors (for structural studies) or transiently transfected HEK293 cells (for biochemical characterization). Purification was carried out by affinity chromatography using a protein G-8B8 column followed by size exclusion chromatography (Superdex 200 Increase 10/300 GL, GE Healthcare) in 20 mM Tris HCl, pH 7.5, 150 mM NaCl, 1 mM CaCl 2 and 1 mM MgCl 2 . Antibodies were purified as described previously 6 . 8B8 and 68 fragments were generated by papain digestion (Pierce) of the IgG followed by protein A-agarose (Millipore) incubation to remove Fc fragments and intact antibodies.
The homogeneity and purity of all protein preparations were verified by SDS-PAGE stained with Coomassie blue, and protein concentrations were measured by micro-bicinchoninic acid assay (Pierce). To prepare integrin-Fab complexes, 100 μ g of recombinant α vβ 8 was incubated in a twofold molar excess of each Fab, incubated at room temperature for 30 min, subjected to size exclusion chromatography and concentrated to 6 to 9 mg/ml. Porcine L-TGF-β was expressed and purified as described 26 .
ns-EM sample preparation, data acquisition and analysis.
Grids of negatively stained integrin samples were prepared following established protocols 27 . Specifically, 2.5 μ l of purified truncated α vβ 3, α vβ 3HP or α vc-cβ 3 sample with a concentration of ~0.02 mg/ml were applied to glow-discharged carbon-coated copper grids, washed, stained with 0.75% (w/v) uranyl formate and aspirated to dryness 6 . Negatively stained grids were imaged on a Tecnai T12 electron microscope (FEI Company) equipped with a LaB 6 filament and operating at a 120 kV acceleration voltage. Images were recorded at a nominal magnification of 52,000× and a defocus of -1.5 μ m using a 4 K CCD camera (UltraScan 4000, Gatan, Inc., Pleasanton, CA), with a corresponding pixel size of 2.21 Å on the specimen. Images were 2 × 2 binned for particle picking and further processing. Particles were picked using reference-free methods as implemented in Gautomatch (http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch) and further processed using the Relion pipeline 28 .
Cryo-EM sample preparation, data acquisition and analysis.
For cryo-EM grid preparation, 3 μ l of purified α vβ 8-8B8-68 complex (6.8 mg/ml concentration) were applied to Quantifoil grids (holey carbon film with 1.2 μ m hole size and 1.3 μ m hole spacing on 400-mesh copper grid), glow-discharged for 60 s at 15 mA, blotted with a Vitrobot Mark III (FEI Company) using 3.5-4.5 s blotting time with 100% humidity at 20 °C, and plunge-frozen in liquid ethane cooled by liquid nitrogen.
Cryo-EM images of frozen hydrated α vβ 8-8B8-68 complexes were collected on a TF30 Polara electron microscope (FEI Company) equipped with a field emission electron source and operated at 300 kV. Images were recorded at a nominal magnification of 31,000× using a K2 Summit direct electron detector camera (Gatan) operated in super-resolution mode following an established protocol 29 . The microscope settings were as follows: extraction voltage 4,200 eV, gun lens 1, spotsize 3, a 30 μ m C2 aperture and a 100 μ m objective aperture. Data were manually collected using UCSFImage4 30 or SerialEM 31 , using a nominal defocus range of -1.8 to -2.8 µ m. The calibrated physical pixel size was 1.22 Å at specimen and a dose rate of 10.12 e -/pixel. A total dose of 41 e -/Å 2 was fractionated over 30 frames during the 6-s exposures. From the cryo-EM images, particles do not have preferred orientation in vitreous ice, but they are found only in thick ice and sparsely distributed. A total of 2,174 movies were collected over three sessions; however, only 713 movies (collected during a single session) were used for the final map.
Dose-fractionated super-resolution image stacks were motion corrected and binned 2 × 2 by Fourier cropping using MotionCor2 32 . Motion-corrected sums without dose weighting were used for contrast transfer function (CTF) determination using GCTF 33 . The relatively low signal-to-noise ratio in Fourier power spectra, due to sparsely distributed particles in thick ice, limits the accuracy of CTF estimation. 144,005 particles were picked using the reference-free method in Gautomatch, boxed out in Relion 2.0 with a box size of 320 pixels and binned to 64 pixels. Upon micrograph inspection, we noted that many of these picks were 'false positives' and did not represent particles but rather ice or debris. This is likely due to the reference-free picking approach. After two rounds of 2D alignment and classification in Relion 2.0 28 , particles were re-extracted and binned to 128 pixels to generate ab initio initial models using CryoSPARC 34 . After 3D alignment and classification in Relion 2.0 to further sort ideal particles from junk, this new smaller subset of particles (17, 442 ) was re-extracted using dose-weighted micrographs and binned to a final box size of 256 pixels (1.67 Å/pixel). Using one of the models generated during 3D classification low-pass filtered to 20 Å as an initial model, initial angles and shifts were determined in Relion 2.0. Frealign 9 35 in mode 1 was used for subsequent refinement and reconstruction. During the refinement, only data up to a resolution of 8 Å were used to avoid possible overfitting and bias in the FSC curves at higher resolution. For the α vβ 8-8B8-68 complex, the resolution of the overall map was estimated to be 6.4 Å. Subsequently, a soft mask was generated to exclude the constant domains of both Fabs as well as calf-1 and calf-2 of the α -subunit and the PSI-EGF1 domains of the β -subunit. This improved the resolution of the α vβ 8-8B8-68 complex to 4.8 Å (resolution limited to 6 Å in Frealign). We speculate that the accuracy of CTF estimation and thick ice are contributing factors that limit the resolution. For the six complexes showing leg motion, the processing schematic is described in Supplementary Fig. 3 and the resolution during refinement was limited to 10 Å in all cases.
Resolutions were determined using FSC = 0.143 criterion 36 . All postprocessing, including mask generation, filtering, sharpening and masked FSC estimation, were done using Relion 2.0. Local resolution was estimated in Bsoft blocres 37 . Map to model FSC was calculated in Rosetta. Images were rendered in UCSF Chimera 38 and Pymol 39 ; the movie was rendered in UCSF Chimera.
Model building and refinement. The atomic model of the α v headpiece from the crystal structure of α vβ 3 (PDB: 3IJE) with glycans removed was fitted to the cryo-EM density of α vβ 8-8B8-68 complex as a rigid body. An atomic model of the β 8 headpiece was generated by rigid-body fitting of a homology model based on the same crystal structure (3IJE) using Modeller 40 into the cryo-EM map. Atomic models of Fabs were generated with Rosetta Antibody using multiple-template grafting and H3 loop modelization 12 based on the primary sequence of their V h and V k . The models for Fab 68 and Fab 8B8 were then fitted as a rigid body to the map. Prototypical CHOLec glycans were added back to the model at the solvent-exposed N-glycosylation consensus sites using GLYCAM 41 . The sugar bases of glycans were trimmed to fit into the corresponding densities. After rigid body fitting, models were manually adjusted in COOT 42 , followed by real space refinement using Phenix 11 and Rosetta.
Integrin mutants constructs. To construct the truncated human α vc-c mutant, we used splice overlap extension PCR. Mutagenesis primers are included in Supplementary Table 3 . The resulting amplicon was cut with PstI and SphI and ligated into α v truncated pcDM8 cut with the same enzymes 43 . To make the full-length α vc-c mutant, truncated α vc-c pcDM8 was cut with BstEII and SphI and ligated into α v full-length pcDM8 cut with the same enzymes.
The human β 3 HP mutant was amplified using primers listed in Supplementary  Table 3 followed by cutting with BamHI and XhoI and ligation into human truncated β 3 pcDNA1neo cut with the same enzymes 44 . All constructs were verified by sequencing.
Ligand binding, cell adhesion assays and cell staining. For ligand binding assays, ELISA plates were coated with 0.5 µ g/ml of L-TGF-β (for α vβ 8 wild-type and α vc-cβ 8) or vitronectin-N (for α vβ 3 wild-type and α vc-cβ 3) and blocked with 5% BSA in PBS for 1 h; truncated integrin was allowed to bind for 2 h at room temperature and bound integrin was detected with 8B8-biotin and streptavidin-HRP. For cell adhesion assays, ELISA plates were coated with various concentrations of vitronectin-N or L-TGF-β and blocked using PBS with 5% BSA for 1 h, and then 50,000 α vβ 3, α vβ 8 α vc-cβ 3 or α vc-cβ 8 CHOLec 3.2.8.1 cells were allowed to adhere to wells for 30 min at room temperature in the presence of 1 mM Ca 2+ and 1 mM Mg 2+ or 0.2 mM Mn 2+ . Cell staining and flow cytometry was performed as previously described 6 .
Sequence alignments. Multiple protein sequence alignments for integrins were generated using Tcoffee 45 .
Statistics. ELISA data are reported as means ± s.e.m. All statistical analyses were performed using the software package 
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Experimental design 1. Sample size
Describe how sample size was determined.
For in vitro assays, sample sizes were determined empirically using years of experience using similar assays. Sample sizes were predetermined for cell culture and biochemical assays based on large expected effect sizes requiring an N=3-4 (a=0.5, b=0.8).
Data exclusions
Describe any data exclusions.
In single particle cryo-EM, we followed the standard procedure to select micrographs and particles from micrograph for further processing.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
In single particle cryo-EM, all data processing is documented. Raw particle stacks and related parameter file will be deposited to database upon publication. For in vitro assays, t lease two replicates were used for each data point in each assay, and experiments were repeated a minimum of 3 times.
Randomization
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The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section. Describe the software used to analyze the data in this study.
All software used in analysis the data are described and proper reference are cited.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
All unique materials used in this study are readily available from the corresponding authors.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Antibody 8B8, anti-human av, ELISA, IP, Flow Cytometry, sequencing, ns-EM Antibody 68, anti-human b8, ELISA, IP, Flow Cytometry, sequencing, ns-EM Antibody AP3, anti-human b3, ELISA, IP, Flow Cytometry, sequencing Antibody AP5, anti-human b3, ELISA, IP, Flow Cytometry, sequencing Antibody LIBS1, anti-human b3, ELISA, IP, Flow Cytometry, sequencing Antibody LIBS6, anti-human b3, ELISA, IP, Flow Cytometry, sequencing 
Description of research animals
Provide all relevant details on animals and/or animal-derived materials used in the study.
We did not use animals for this study Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
Human subjects were not used
